Masarykova univerzita

Výpis publikací

česky | in English

Filtrování publikací

    2021

  1. DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ a Michaela BOSÁKOVÁ. Thermostable FGF2 Polypeptide, Use Thereof. 2021. Patent. Číslo: SG11201804402W. Vydavatel: Intellectual Property Office of Singapore (IPOS). Místo vydání: Singapur. Název vlastníka: Masarykova univerzita; Enantis s.r.o. Datum registrace: 3. 10. 2016. Datum přijetí: 5. 4. 2021.
  2. 2020

  3. BARAD, M., F. CSUKASI, Michaela BOSÁKOVÁ, J. H. MARTIN, W. J. ZHANG, S. P. TAYLOR, R. S. LACHMAN, J. ZIEBA, M. BAMSHAD, D. NICKERSON, J. X. CHONG, D. H. COHN, Pavel KREJČÍ, D. KRAKOW a I. DURAN. Biallelic mutations in LAMA5 disrupts a skeletal noncanonical focal adhesion pathway and produces a distinct bent bone dysplasia. EBioMedicine. Amsterdam: Elsevier Science BV, 2020, roč. 62, DEC 2020, s. 1-13. ISSN 2352-3964. doi:10.1016/j.ebiom.2020.103075.
  4. GREGOR, Tomáš, Michaela BOSÁKOVÁ, Alexandru NITĂ, Sara POOVAKULATHU ABRAHAM, Bohumil FAFÍLEK, Nicole ČERNOHORSKÁ, Jan RYNEŠ, Silvie TRANTÍRKOVÁ, Daniela ŽÁČKOVÁ, Jiří MAYER, Lukáš TRANTÍREK a Pavel KREJČÍ. Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex. Cellular and molecular life sciences. BASEL: SPRINGER BASEL AG, 2020, roč. 77, č. 19, s. 3885-3903. ISSN 1420-682X. doi:10.1007/s00018-019-03397-7.
  5. BOSÁKOVÁ, Michaela, Sara POOVAKULATHU ABRAHAM, Alexandru NITĂ, Eva HRUBA, Marcela BUCHTOVA, S. Paige TAYLOR, Ivan DURAN, Jorge MARTIN, Kateřina SVOZILOVÁ, Tomáš BÁRTA, Miroslav VAŘECHA, Lukáš BÁLEK, Jiri KOHOUTEK, Tomasz Witold RADASZKIEWICZ, Ganesh V. PUSAPATI, Vítězslav BRYJA, Eric T. RUSH, Isabelle THIFFAULT, Deborah A. NICKERSON, Michael J. BAMSHAD, Rajat ROHATGI, Daniel H. COHN, Deborah KRAKOW a Pavel KREJČÍ. Mutations in GRK2 cause Jeune syndrome by impairing Hedgehog and canonical Wnt signaling. EMBO MOLECULAR MEDICINE. HOBOKEN: WILEY-BLACKWELL, 2020, roč. 12, č. 11, s. 1-20. ISSN 1757-4676. doi:10.15252/emmm.201911739.
  6. DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ a Michaela BOSÁKOVÁ. Thermostable FGF2 Polypeptide, Use Thereof. 2020. Patent. Číslo: EP3380508. Vydavatel: European Patent Office. Místo vydání: Munich. Název vlastníka: Masarykova univerzita; Enantis s.r.o. Datum registrace: 3. 10. 2016. Datum přijetí: 22. 7. 2020.
  7. 2019

  8. KREJČÍ, Pavel. C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia. New England Journal of Medicine. Waltham: Massachussetts Medical Society, 2019, roč. 381, č. 13, s. 1291. ISSN 0028-4793. doi:10.1056/NEJMc1910394.
  9. HRUBA, E., M. KAVKOVA, T. ZIKMUND, M. HOVORAKOVA, L. DALECKA, Michaela BOSÁKOVÁ, Pavel KREJČÍ a M. BUCHTOVA. Deficiency of Sprouty Proteins in Mice Resemble Ciliopathic Phenotype. In International Congress of Vertebrate Morphology (ICVM). 2019. ISSN 0362-2525.
  10. BOSÁKOVÁ, Michaela, Alexandru NITĂ, Tomáš GREGOR, Miroslav VAŘECHA, Iva GUDERNOVÁ, Bohumil FAFÍLEK, Tomáš BÁRTA, Neha BASHEER, Sara POOVAKULATHU ABRAHAM, Lukáš BÁLEK, Markéta TOMANOVÁ, Jana FIALOVÁ KUČEROVÁ, Juraj BOSÁK, David POTĚŠIL, Jennifer ZIEBA, Jieun SONG, Peter KONIK, Sohyun PARK, Ivan DURAN, Zbyněk ZDRÁHAL, David ŠMAJS, Gert JANSEN, Zheng FU, Hyuk Wan KO, Aleš HAMPL, Lukáš TRANTÍREK, Deborah KRAKOW a Pavel KREJČÍ. Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase. Proceedings of the National Academy of Sciences of the United States of America. WASHINGTON: NATL ACAD SCIENCES, 2019, roč. 116, č. 10, s. 4316-4325. ISSN 0027-8424. doi:10.1073/pnas.1800338116.
  11. 2018

  12. BOSÁK, Juraj, Lenka MICENKOVÁ, Matěj HRALA, Katarína POMORSKÁ, Michaela BOSÁKOVÁ, Pavel KREJČÍ, Eduard GÖPFERT, Martin FALDYNA a David ŠMAJS. Colicin F-Y inhibits pathogenic Yersinia enterocolitica in mice. Scientific reports. London: NATURE PUBLISHING GROUP, 2018, roč. 8, č. 12242, s. 1-12. ISSN 2045-2322. doi:10.1038/s41598-018-30729-7.
  13. DVOŘÁK, Pavel, David BEDNÁŘ, Pavel VAŇÁČEK, Lukáš BÁLEK, Lívia EISELLEOVÁ, Veronika ŠTĚPÁNKOVÁ, Eva ŠEBESTOVÁ, Michaela BOSÁKOVÁ, Žaneta KONEČNÁ, Stanislav MAZURENKO, Antonín KUNKA, Tereza VÁŇOVÁ, Karolína ZOUFALOVÁ, Radka CHALOUPKOVÁ, Jan BREZOVSKÝ, Pavel KREJČÍ, Zbyněk PROKOP, Petr DVOŘÁK a Jiří DAMBORSKÝ. Computer-assisted engineering of hyperstable fibroblast growth factor 2. Biotechnology and Bioengineering. New York: Wiley, 2018, roč. 115, č. 4, s. 850-862. ISSN 0006-3592. doi:10.1002/bit.26531.
  14. GHOSH, Somadri, Samuel SCOZZARO, Ana Raque RAMOS, Seprimebastien DELCAMBRE, Cleprimement CHEVALIER, Pavel KREJČÍ a Christophe ERNEUX. Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells. Journal of Cell Science. Cambridge: Company of Biologists Ltd., 2018, roč. 131, č. 16, s. 1-12. ISSN 0021-9533. doi:10.1242/jcs.216408.
  15. BÁLEK, Lukáš, marcela BUCHTOVÁ, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Silvie TRANTÍRKOVÁ, Iva GUDERNOVÁ, Iva VESELÁ, Jan HAVLIK, Jitka NEBURKOVA, Stuart TURNER, Mateusz Adam KRZYSCIK, Malgorzata ZAKRZEWSKA, Lars KLIMASCHEWSKI, Peter CLAUS, Lukáš TRANTÍREK, Petr CIGLER a Pavel KREJČÍ. Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals. Biomaterials. OXFORD: ELSEVIER SCI LTD, 2018, roč. 176, SEP 2018, s. 106-121. ISSN 0142-9612. doi:10.1016/j.biomaterials.2018.05.030.
  16. BÁLEK, Lukáš, Pavel NĚMEC, P. KONIK, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Iva GUDERNOVÁ, Jiřina MEDALOVÁ, Deborah KRAKOW a Pavel KREJČÍ. Proteomic analyses of signalling complexes associated with receptor tyrosine kinase identify novel members of fibroblast growth factor receptor 3 interactome. Cellular Signalling. New York: Elsevier Science, 2018, roč. 42, JAN 2018, s. 144-154. ISSN 0898-6568. doi:10.1016/j.cellsig.2017.10.003.
  17. PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ a Pavel KREJČÍ. Registr Achondroplasie na Slovensku a v České republice. In Stretnutie Palčekov v Bojniciach - Hlbokom. 2018.
  18. PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ a Pavel KREJČÍ. Registr Achondroplázie REACH. In Den Vzácných Onemocnění 2018. 2018.
  19. BOSÁKOVÁ, Michaela, Miroslav VAŘECHA, Marek HAMPL, Ivan DURAN, Alexandru NITĂ, marcela BUCHTOVÁ, Hana DOSEDELOVA, Radek MACHÁT, Yangli XIE, Zhenhong NI, Jorge H. MARTIN, Lin CHEN, Gert JANSEN, Deborah KRAKOW a Pavel KREJČÍ. Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies. Human molecular genetics. OXFORD: OXFORD UNIV PRESS, 2018, roč. 27, č. 6, s. 1093-1105. ISSN 0964-6906. doi:10.1093/hmg/ddy031.
  20. FAFÍLEK, Bohumil, Lukáš BÁLEK, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Alexandru NITĂ, Tomáš GREGOR, Iva GUDERNOVÁ, Jitka KŘENOVÁ, S. GHOSH, Martin PISKÁČEK, Lucie JONATOVA, Nicole ČERNOHORSKÁ, J.T. ZIEBA, M. KOSTAS, E.M. HAUGSTEN, J. WESCHE, C. ERNEUX, Lukáš TRANTÍREK, D. KRAKOW a Pavel KREJČÍ. The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases. SCIENCE SIGNALING. WASHINGTON: AMER ASSOC ADVANCEMENT SCIENCE, 2018, roč. 11, č. 548, s. 1-14. ISSN 1945-0877. doi:10.1126/scisignal.aap8608.
  21. CSUKASI, F., I. DURAN, M. BARAD, Tomáš BÁRTA, Iva GUDERNOVÁ, Lukáš TRANTÍREK, J.H. MARTIN, C.Y. KUO, J. WOODS, H. LEE, D.H. COHN, Pavel KREJČÍ a D. KRAKOW. The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling. Science Translational Medicine. Washington: American Association for the Advancement of Science, 2018, roč. 10, č. 459, s. 1-11. ISSN 1946-6234. doi:10.1126/scitranslmed.aat9356.
  22. 2017

  23. DURAN, Ivan, Jorge H. MARTIN, Mary Ann WEIS, Pavel KREJČÍ, Peter KONIK, Bing LI, Yasemin ALANAY, Caressa LIETMAN, Brendan LEE, David EYRE, Daniel H. COHN a Deborah KRAKOW. A Chaperone Complex Formed by HSP47, FKBP65 and BiP Modulates Telopeptide Lysyl Hydroxylation of Type I Procollagen. Journal of Bone and Mineral Research. Hoboken: Wiley-Blackwell, 2017, roč. 32, č. 6, s. 1309-1319. ISSN 0884-0431. doi:10.1002/jbmr.3095.
  24. BERNATÍK, Ondřej, Tomasz Witold RADASZKIEWICZ, Martin BĚHAL, Zankruti DAVE, Florian WITTE, Annika MAHL, Nicole ČERNOHORSKÁ, Pavel KREJČÍ, Sigmar STRICKER a Vítězslav BRYJA. A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation. Frontiers in Cell and Developmental Biology. Lausanne: Frontiers Media S.A., 2017, roč. 5, MAY, s. 1-9. ISSN 2296-634X. doi:10.3389/fcell.2017.00047.
  25. BÁLEK, Lukáš, Iva GUDERNOVÁ, Iva VESELA, Marek HAMPL, Veronika ORALOVÁ, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Pavel NĚMEC, Terence HALL, Giovanni ABBADESSA, Nan HATCH, marcela BUCHTOVÁ a Pavel KREJČÍ. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3. Bone. NEW YORK: Elsevier, 2017, roč. 105, DEC 2017, s. 57-66. ISSN 8756-3282. doi:10.1016/j.bone.2017.08.016.
  26. KILLINGER, Michael, Eva HRUBÁ, Miroslav VAŘECHA, Pavel KREJČÍ a marcela BUCHTOVÁ. Differences in anterior-posterior sensitivity of early limb bud cell to FGF/WNT treatment. In BSDB/Nordic conference on developmental biology and regeneration. 2017.
  27. GUDERNOVÁ, Iva, Lukáš BÁLEK, Miroslav VAŘECHA, Jana FIALOVÁ KUČEROVÁ, Michaela BOSÁKOVÁ, Bohumil FAFÍLEK, Veronika PALUŠOVÁ, Stjepan ULDRIJAN, Lukáš TRANTÍREK a Pavel KREJČÍ. Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480. Oncotarget. New York: Impact Journals LLC, 2017, roč. 8, č. 65, s. 109319-109331. ISSN 1949-2553. doi:10.18632/oncotarget.22674.
  28. GUDERNOVÁ, Iva, Silvie TRANTÍRKOVÁ, Barbora EL GHANNAMOVÁ, Bohumil FAFÍLEK, Miroslav VAŘECHA, Lukáš BÁLEK, Eva HRUBÁ, Lucie JONÁTOVÁ, Iva JELÍNKOVÁ, Michaela BOSÁKOVÁ, Lukáš TRANTÍREK, Jiří MAYER a Pavel KREJČÍ. One reporter for in-cell activity profiling of majority of protein kinase oncogenes. eLife. Cambridge: eLife Sciences Publications Ltd., 2017, roč. 6, "e21536", s. 1-14. ISSN 2050-084X. doi:10.7554/eLife.21536.
  29. PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ a Pavel KREJČÍ. REACH Registr Achondroplázie v roce 2017. In Celostátní konference Paleček 2017. 2017.
  30. PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ a Pavel KREJČÍ. Registr Achondroplasie a možnosti léčby souvisejících poruch růstu. In BRNĚNSKÝ GENETICKÝ DEN 2017. 2017.
  31. HAMPL, Marek, P. CELA, H.L. SZABO-ROGERS, Michaela BOSÁKOVÁ, H. DOSEDELOVA, Pavel KREJČÍ a marcela BUCHTOVÁ. Role of Primary Cilia in Odontogenesis. Journal of Dental Research. THOUSAND OAKS, CA USA: SAGE PUBLICATIONS INC, 2017, roč. 96, č. 9, s. 965-974. ISSN 0022-0345. doi:10.1177/0022034517713688.
  32. FAFÍLEK, Bohumil, Marek HAMPL, Nikola ŘIČÁNKOVÁ, I. VESELA, Lukáš BÁLEK, Michaela BOSÁKOVÁ, Iva GUDERNOVÁ, Miroslav VAŘECHA, marcela BUCHTOVÁ a Pavel KREJČÍ. Statins do not inhibit the FGFR signaling in chondrocytes. Osteoarthritis and Cartilage. Oxford: Elsevier Science Inc., 2017, roč. 25, č. 9, s. 1522-1530. ISSN 1063-4584. doi:10.1016/j.joca.2017.05.014.
  33. GREGOR, Tomáš, Jan RYNEŠ, Silvie TRANTÍRKOVÁ, Jiří MAYER, Pavel KREJČÍ a Lukáš TRANTÍREK. Systematic analysis of BCR-ABL interactome in chronic myeloid leukemia. In 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back. 2017. ISSN 1742-464X.
  34. VÁŇOVÁ, Tereza, Žaneta KONEČNÁ, Zuzana ZBOŇÁKOVÁ, Giuseppe LA VENUTA, Karolína ZOUFALOVÁ, Šárka JELÍNKOVÁ, Miroslav VAŘECHA, Vladimír ROTREKL, Pavel KREJČÍ, Walter NICKEL, Petr DVOŘÁK a Michaela BOSÁKOVÁ. Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion. Stem Cells. UNITED STATES: WILEY-BLACKWELL, 2017, roč. 35, č. 9, s. 2050-2059. ISSN 1066-5099. doi:10.1002/stem.2660.
  35. 2016

  36. TAYLOR, S. Paige, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Lukáš BÁLEK, Tomáš BÁRTA, Lukáš TRANTÍREK, Iva JELÍNKOVÁ, Ivan DURAN, Iva VESELÁ, Kimberly N. FORLENZA, Jorge H. MARTIN, Aleš HAMPL, Michael BAMSHAD, Deborah NICKERSON, Margie L. JAWORSKI, Jieun SONG, Hyuk WAN KO, Daniel H. COHN, Deborah KRAKOW a Pavel KREJČÍ. An inactivating mutation in intestinal cell kinase, ICK, impairs hedgehog signalling and causes short rib-polydactyly syndrome. Human Molecular Genetics. Oxford: Oxford University Press, 2016, roč. 25, č. 18, s. 3998-4011. ISSN 0964-6906. doi:10.1093/hmg/ddw240.
  37. KILLINGER, Michael, Petra CELÁ, Pavel KREJČÍ a marcela BUCHTOVÁ. Effect of WNT5a and WNT7a on chondrogenesis during limb development. In EMBO Conference: Wnt Meeting 2016. 2016.
  38. CELÁ, Petra, Marek HAMPL, Katherine K. FU, Michaela BOSÁKOVÁ, Pavel KREJČÍ, Joy M. RICHMAN a marcela BUCHTOVÁ. MORN5 Expression during Craniofacial Development and Its Interaction with the BMP and TGF beta Pathways. Frontiers in Physiology. Lausanne: FRONTIERS MEDIA SA, 2016, roč. 7, August, s. nestránkováno, 12 s. ISSN 1664-042X. doi:10.3389/fphys.2016.00378.
  39. GUDERNOVÁ, Iva, Iva VESELA, Lukáš BÁLEK, marcela BUCHTOVÁ, Hana DOSEDELOVA, Michaela KUNOVÁ, Jakub PIVNIČKA, Iva JELÍNKOVÁ, Lucie ROUBALOVA, Alois KOZUBÍK a Pavel KREJČÍ. Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short stature syndromes. Human Molecular Genetics. Oxford: Oxford University Press, 2016, roč. 25, č. 1, s. 9-23. ISSN 0964-6906. doi:10.1093/hmg/ddv441.
  40. PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ, Hana HRSTKOVÁ a Pavel KREJČÍ. NOVEL THERAPEUTIC APPROACHES TO ACHONDROPLASIA AND SETTING UP CZECH REGISTRY. In EUROPEAN SOCIETY OF PEDIATRIC CLINICAL RESEARCH MEETING 2016. 2016. ISSN 1805-4501.
  41. HAUGSTEN, Ellen Margrethe, Vigdis SØRENSEN, Michaela BOSÁKOVÁ, Gustavo Antonio de SOUZA, Pavel KREJČÍ, Antoni WIEDLOCHA a Jørgen WESCHE. Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport. Journal of Proteome Research. Washington: American Chemical Society, 2016, roč. 15, č. 10, s. 3841-3855. ISSN 1535-3893. doi:10.1021/acs.jproteome.6b00652.
  42. PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ a Pavel KREJČÍ. REACH Registr Achondroplázie v roce 2016. In Celostátní konference Paleček 2016. 2016.
  43. HAJNAL, Matej, David ŠAFRÁNEK, Martin DEMKO, Samuel PASTVA, Pavel KREJČÍ a Luboš BRIM. Toward Modelling and Analysis of Transient and Sustained Behaviour of Signalling Pathways. In Eugenio Cinquemani. Hybrid Systems Biology. HSB 2016. LNBI 9957. Neuveden: Springer International Publishing, 2016. s. 57-66. ISBN 978-3-319-47150-1. doi:10.1007/978-3-319-47151-8_4.
  44. 2015

  45. KANT, Sarina G., Iveta ČERVENKOVÁ, Lukáš BÁLEK, Lukáš TRANTÍREK, Gijs W. E. SANTEN, Martine C. de VRIES, Hermine A. van DUYVENVOORDE, Michiel J. R. van der WIELEN, Annemieke J. M. H. VERKERK, André G. UITTERLINDEN, Sabine E. HANNEMA, Jan M. WIT, Wilma OOSTDIJK, Pavel KREJČÍ a Monique LOSEKOOT. A novel variant of FGFR3 causes proportionate short stature. European Journal od Endocrinology. Bristol: Bioscientifica LTD, 2015, roč. 172, č. 6, s. 763-770. ISSN 0804-4643. doi:10.1530/EJE-14-0945.
  46. STOKLASA, Roman, Lukáš BÁLEK, Pavel KREJČÍ a Petr MATULA. Automated Cell Segmentation in Phase-Contrast Images based on Classification and Region Growing. In Proceedings of 2015 IEEE International Symposium on Biomedical Imaging, 2015. Neuveden: Engineering in Medicine and Biology Society, 2015. s. 1447-1451. ISBN 978-1-4799-2374-8. doi:10.1109/ISBI.2015.7164149.
  47. CELÁ, Petra, Michael KILLINGER, Veronika ORALOVÁ, Iva VESELÁ, Pavel KREJČÍ a marcela BUCHTOVÁ. Cross-talk of FGF and WNT signaling pathways during limb development. In 2015 cell biology ascb annual meeting. San Francisco. 2015.
  48. DOSEDĚLOVÁ, Hana, Jana DUMKOVÁ, Hervé LESOT, Kristýna GLOCOVÁ, Michaela KUNOVÁ, Abigail S. TUCKER, Iva VESELÁ, Pavel KREJČÍ, František TICHÝ, Aleš HAMPL a marcela BUCHTOVÁ. Fate of the Molar Dental Lamina in the Monophyodont Mouse. Plos one. San Francisco: Public Library Science, 2015, roč. 10, č. 5, s. nestránkováno, 22 s. ISSN 1932-6203. doi:10.1371/journal.pone.0127543.
  49. BUCHTOVÁ, marcela, Veronika ORALOVÁ, Anie AKLIAN, Jan MAŠEK, Iva VESELA, Zhufeng OUYANG, Tereza OBADALOVÁ, Žaneta KONEČNÁ, Tereza SPOUSTOVÁ, Tereza POSPÍŠILOVÁ, Petr MATULA, Miroslav VAŘECHA, Lukáš BÁLEK, Iva GUDERNOVÁ, Iva JELÍNKOVÁ, Ivan DURAN, Iveta ČERVENKOVÁ, Shunichi MURAKAMI, Alois KOZUBÍK, Petr DVOŘÁK, Vítězslav BRYJA a Pavel KREJČÍ. Fibroblast growth factor and canonical WNT/beta-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage. Biochimica et Biophysica Acta - Molecular Basis of Disease. Amsterdam: ELSEVIER SCIENCE BV, 2015, roč. 1852, č. 5, s. 839-850. ISSN 0925-4439. doi:10.1016/j.bbadis.2014.12.020.
  50. DURAN, Ivan, Lisette NEVAREZ, Anna SARUKHANOV, Sulin WU, Katrina LEE, Pavel KREJČÍ, Maryann WEIS, David EYRE, Deborah KRAKOW a Daniel H. COHN. HSP47 and FKBP65 cooperate in the synthesis of type I procollagen. Human Molecular Genetics. Oxford: Oxford Univ Press, 2015, roč. 24, č. 7, s. 1918-1928. ISSN 0964-6906. doi:10.1093/hmg/ddu608.
  51. BUCHTOVÁ, marcela, Radka CHALOUPKOVÁ, Malgorzata ZAKRZEWSKA, Iva VESELÁ, Petra CELÁ, Jana BARÁTHOVÁ, Iva GUDERNOVÁ, Renata ZAJICKOVA, Lukáš TRANTÍREK, Jorge MARTIN, Martin KOSTAS, Jacek OTLEWSKI, Jiří DAMBORSKÝ, Alois KOZUBÍK, Antoni WIEDLOCHA a Pavel KREJČÍ. Instability restricts signaling of multiple fibroblast growth factors. Cellular and Molecular Life Sciences. Basel: Springer, 2015, roč. 72, č. 12, s. 2445-2459. ISSN 1420-682X. doi:10.1007/s00018-015-1856-8.
  52. BRYJA, Vítězslav, Pavel KREJČÍ, Markéta KAUCKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Alois KOZUBÍK, Jana KOTAŠKOVÁ a Karla PLEVOVÁ. Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method. 2015. Patent. Číslo: US 9,057,106. Vydavatel: United States Patents and Trademark. Místo vydání: USA. Název vlastníka: Masarykova univerzita. Datum registrace: 3. 8. 2010. Datum přijetí: 16. 6. 2015.
  53. WENDT, Daniel J., Melita DVORAK-EWELL, Sherry BULLENS, Florence LORGET, Sean M. BELL, Jeff PENG, Sianna CASTILLO, Mika AOYAGI-SCHARBER, Charles A. O'NEILL, Pavel KREJČÍ, William R. WILCOX, David L. RIMOIN a Stuart BUNTING. Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3-Related Dwarfism. Journal of Pharmacology and Experimental Therapeutics. Bethesda: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 2015, roč. 353, č. 1, s. 132-149. ISSN 0022-3565. doi:10.1124/jpet.114.218560.
  54. SKUTKOVÁ, Linda, Martin PEŠL a Pavel KREJČÍ. Nové terapeutické možnosti achondroplázie a založení registru pro malé lidi v ČR. In XXXI. Neonatologické dny. 2015. ISSN 1211-1600.
  55. PEŠL, Martin, Linda SKUTKOVÁ, Jana STRENKOVÁ a Pavel KREJČÍ. Příprava Registru Achondroplázie REACH. In Celostátní konference Paleček 2015. 2015.
  56. KREJČÍ, Pavel. Putting the brakes on chondrosarcoma. Oncotarget. New York: Impact Journals, 2015, roč. 6, č. 28, s. 24598. ISSN 1949-2553. doi:10.18632/oncotarget.5242.
  57. 2014

  58. HORAKOVA, Dana, Petra CELÁ, Pavel KREJČÍ, Lukáš BÁLEK, Simona MORAVCOVÁ BALKOVÁ, Eva MATALOVA a Marcela BUCHTOVA. Effect of FGFR inhibitors on chicken limb development. Development Growth & Differentiation. Hoboken, USA: WILEY-BLACKWELL, 2014, roč. 56, č. 8, s. 555-572. ISSN 0012-1592. doi:10.1111/dgd.12156.
  59. BOSÁKOVÁ, Michaela, Pavel KREJČÍ, Lukáš TRANTÍREK a Petr DVOŘÁK. FGF19/BETA-KLOTHO REGULATE PHYSIOLOGY AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS. In ISSCR 12th Annual Meeting, Vancouver, Canada, June 18-21 2014. 2014.
  60. SALAZAR, Lisa, Tamar KASHIWADA, Pavel KREJČÍ, April MEYER, Malcolm CASALE, Matthew HALLOWELL, William WILCOX, Daniel DONOGHUE a Leslie MICHELS THOMPSON. Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFbeta-Activated Kinase 1 Tyrosine Phosphorylation and NFkappaB Signaling in Multiple Myeloma and Bladder Cancer. PLOS One. San Francisco: Public Library of Science, 2014, roč. 9, č. 1, s. "nestrankovano", 13 s. ISSN 1932-6203. doi:10.1371/journal.pone.0086470.
  61. EZGU, F. S., Pavel KREJČÍ, S. LI, Carlos DE SOUSA, JM GRAHAM, I. HANSMANN, W. HE, K. PORPORA, Dorothea WAND, W. WERTELECKI, A. SCHNEIDER a William R. WILCOX. Phenotype-genotype correlations in patients with Marinesco-Sjogren syndrome. Clinical Genetics. Hoboken: Wiley-Blackwell, 2014, roč. 86, č. 1, s. 74-84. ISSN 0009-9163. doi:10.1111/cge.12230.
  62. KONEČNÁ, Žaneta, Tereza VÁŇOVÁ, Michaela BOSÁKOVÁ, Pavel KREJČÍ a Petr DVOŘÁK. TEC KINASE MODULATES AUTOCRINE/PARACRINE FGF2 SIGNALING IN HUMAN PLURIPOTENT STEM CELLS. In ISSCR 12th Annual Meeting, Vancouver, Canada, June 18-21 2014. 2014.
  63. KREJČÍ, Pavel. The paradox of FGFR3 signaling in skeletal dysplasia: Why chondrocytes growth arrest while other cells over proliferate. Mutation Research - Reviews in Mutation Research. Amsterdam: Elsevier Science, 2014, roč. 759, January–March, s. 40-48. ISSN 1383-5742. doi:10.1016/j.mrrev.2013.11.001.
  64. 2013

  65. KREJČÍ, Pavel, Michaela KUNOVÁ, Iva KUBÍKOVÁ, Lukáš TRANTÍREK, Alois KOZUBÍK a Petr DVOŘÁK. Expression of FGF19 in Human Embryonic Stem Cells. STEM CELLS. HOBOKEN: WILEY-BLACKWELL, 2013, roč. 31, č. 11, s. 2582-2584. ISSN 1066-5099. doi:10.1002/stem.1493.
  66. EZGU, Fatih, Pavel KREJČÍ a William R. WILCOX. Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene. Gene. Amsterdam: Elsevier, 2013, roč. 524, č. 2, s. 403-406. ISSN 0378-1119. doi:10.1016/j.gene.2013.03.026.
  67. KAUCKÁ, Markéta, Karla PLEVOVÁ, Šárka PAVLOVÁ, Pavlína JANOVSKÁ, Archana SHAIK, Jan VERNER, Jiřina PROCHÁZKOVÁ, Pavel KREJČÍ, Jana KOTAŠKOVÁ, Petra OVESNÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Alois KOZUBÍK, Jiří MAYER, Šárka POSPÍŠILOVÁ a Vítězslav BRYJA. The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration. Cancer Research. USA: American Association for Cancer Research, 2013, roč. 73, č. 5, s. 1491-1501. ISSN 0008-5472. doi:10.1158/0008-5472.CAN-12-1752.
  68. 2012

  69. KOČÍ, Lenka, Katarína CHLEBOVÁ, Martina HÝŽĎALOVÁ, Jiřina HOFMANOVÁ, Miroslav JÍRA, Petr KYSELA, Alois KOZUBÍK, Zdeněk KALA a Pavel KREJČÍ. Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivo. Oncology Letters. Spandidos Publ., 2012, roč. 3, č. 4, s. 913-916. ISSN 1792-1074. doi:10.3892/ol.2012.593.
  70. MERRILL, A.E., A. SARUKHANOV, Pavel KREJČÍ, B. IDONI, N. CAMACHO, K.D. ESTRADA, K.M. LYONS, H. DEIXLER, H. ROBINSON, D. CHITAYAT, C.J. CURRY, R.S. LACHMAN, W.R. WILCOX a D. KRAKOW. Bent Bone Dysplasia-FGFR2 type, a Distinct Skeletal Disorder, Has Deficient Canonical FGF Signaling. The American Journal of Human Genetics. Chicago: University of Chicago Press, 2012, roč. 90, č. 3, s. 550-557. ISSN 0002-9297. doi:10.1016/j.ajhg.2012.02.005.
  71. LEE, Hane, J.M. GRAHAM, D.L. RIMOIN, R.S. LACHMAN, Pavel KREJČÍ, S.W. TOMPSON, S.F. NELSON, D. KRAKOW a D.H. COHN. Exome Sequencing Identifies PDE4D mutations in Acrodysostosis. The American Journal of Human Genetics. Chicago: University of Chicago Press, 2012, roč. 90, č. 4, s. 746-751. ISSN 0002-9297. doi:10.1016/j.ajhg.2012.03.004.
  72. WANG, Y., X. ZHOU, K. OBEROI, R. PHELPS, R. COUWENHOVEN, M. SUN, A. REZZA, G. HOLMES, Ch.J. PERCIVAL, J. FRIEDENTHAL, Pavel KREJČÍ, J.T. RICHTSMEIER, D.L. HUSO, Michael RENDL a E. WANG JABS. p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. The journal of clinical investigation. [New York, N.Y.]: American Society for Clinical Investigation, 2012, roč. 122, č. 6, s. 2153-2164. ISSN 0021-9738. doi:10.1172/JCI62644.
  73. KREJČÍ, Pavel, Anie AKLIAN, Markéta KAUCKÁ, Eva ŠEVČÍKOVÁ, Jiřina PROCHÁZKOVÁ, Pavol MIKOLKA, Lukáš BÁLEK, Tereza POSPÍŠILOVÁ, Tereza SPOUSTOVÁ, Vítězslav BRYJA, Iva VESELÁ, Alois KOZUBÍK, MaryAnn WEIS, W.A. PAZNEKAS, J.H. WOLF, J.S. GUTKIND, W.A. WILCOX, E. WNAG JABS, Lisa SALAZAR a Jan Kukla MAŠEK. Receptor tyrosine kinases activate canonical WNT/beta catenin signaling via MAP kinase/LRP6 pathway and direct beta-Catenin phosphorylation. Plos One. 2012, roč. 7, č. 4, s. 1-14. ISSN 1932-6203. doi:10.1371/journal.pone.0035826.
  74. FOLDYNOVA-TRANTIRKOVA, Silvie, W.R. WILCOX a Pavel KREJČÍ. Sixteen years and counting: the current understanding of fibroblast growth factorreceptor 3 (FGFR3) signaling in skeletal dysplasias. Human Mutation. 2012, roč. 33, č. 1, s. 29-41. ISSN 1059-7794. doi:10.1002/humu.21636.
  75. BRYJA, Vítězslav, Pavel KREJČÍ, Markéta KAUCKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Alois KOZUBÍK, Karla MALINOVÁ a Jana KOTAŠKOVÁ. Způsob stanovení závažnosti a prognózy B-buněčné chronické lymfocytární leukémie. 2012. Patent. Číslo: 303555. Název vlastníka: Masarykova Univerzita, Brno, CZ. Datum přijetí: 24. 10. 2012.
  76. 2011

  77. ČERVENKA, Igor, Joshua WOLF, Jan MAŠEK, Pavel KREJČÍ, William R. WILCOX, Alois KOZUBÍK, Gunnar SCHULTE, Silvio J. GUTKIND a Vítězslav BRYJA. Mitogen-Activated Protein Kinases Promote WNT/beta-Catenin Signaling via Phosphorylation of LRP6. Molecular and cellular biology. 2011, roč. 31, č. 1, s. 179-189. ISSN 0270-7306. doi:10.1128/MCB.00550-10.
  78. ČERVENKA, Igor, Joshua WOLF, Jan MAŠEK, Pavel KREJČÍ, William R WILCOX, Alois KOZUBÍK, Gunnar SCHULTE, J Silvio GUTKIND a Vítězslav BRYJA. Mitogen-Activated Protein Kinases Promote WNT/beta-Catenin Signaling via Phosphorylation of LRP6. January 2011. Washington, D.C.: ASM, 2011, roč. 31, č. 1, s. 179-189. ISSN 0270-7306. doi:10.1128/MCB.00550-10.
  79. KAUCKÁ, Markéta, Pavel KREJČÍ, Karla PLEVOVÁ, Šárka PAVLOVÁ, Jiřina PROCHÁZKOVÁ, Pavlína JANOVSKÁ, Jana VALNOHOVÁ, Alois KOZUBÍK, Šárka POSPÍŠILOVÁ a Vítězslav BRYJA. Post-translational modifications regulate signalling by Ror1. Acta Physiologica. Oxford: Blackwell Publishing, 2011, roč. 203, č. 3, s. 351-362. ISSN 1748-1708. doi:10.1111/j.1748-1716.2011.02306.x.
  80. BERNATÍK, Ondřej, Sri Ranjani GANJI, Jacomijn DIJKSTERHUIS, Peter KONIK, Igor ČERVENKA, Tilman POLONIO, Pavel KREJČÍ, Gunnar SCHULTE a Vítězslav BRYJA. Sequential activation and inactivation of dishevelled in the Wnt/{beta}-catenin pathway by casein kinases. Journal of Biological Chemistry. Bethesda, USA: Amer. Soc. Biochem. Mol. Biol., 2011, roč. 286, č. 12, s. 10396-10410. ISSN 0021-9258. doi:10.1074/jbc.M110.169870.
  81. SCUTO, A., Pavel KREJČÍ, L. POPPLEWELL, J. WU, Y. WANG, M. KUJAWSKI, C. KOWOLIK, H. XIN, L. CHEN, Y. WANG, L. KRETZNER, H. YU, W.R. WILCOX, Y. YEN, S. FORMAN a R. JOVE. The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting insuppression of human myeloma cell growth and survival. Leukemia. London : England: Nature Publishing Group, Specialist Jour, 2011, roč. 25, č. 3, s. 538-550. ISSN 0887-6924. doi:10.1038/leu.2010.289.
  82. KAUCKÁ, Markéta, Jan VERNER, Jiřina PROCHÁZKOVÁ, Karla PLEVOVÁ, Olga STEHLÍKOVÁ, Pavel KREJČÍ, Alois KOZUBÍK, Jiří MAYER, Šárka POSPÍŠILOVÁ a Vítězslav BRYJA. Wnt/PCP pathway regulates B-cell migration in chronic lymphocytic leukemia. In XIV. International workshop on chronic lymphocytic leukemia in Clinical Lymphoma, Myeloma and Leukemia. 2011. ISSN 2152-2650.
  83. 2010

  84. FOLDYNOVÁ-TRANTÍRKOVÁ, S., P. SEKYROVÁ, Kateřina TMEJOVÁ, E. BRUMOVSKÁ, Ondřej BERNATÍK, W. BLANKENFELDT, Pavel KREJČÍ, Alois KOZUBÍK, T. DOLEZAL, Lukáš TRANTÍREK a Vítězslav BRYJA. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Research. London, Great Britain: Biomed Central Ltd., 2010, roč. 2010, 12/3, s. 30-31. ISSN 1465-5411. doi:10.1186/bcr2581.
  85. KREJČÍ, Pavel, Jiřina PROCHÁZKOVÁ, Jiří SMUTNÝ, Katarína CHLEBOVÁ, Patricia LIN, Anie AKLIAN, Vítězslav BRYJA, Alois KOZUBÍK a William R. WILCOX. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. Bone. USA: Elsevier Science, 2010, neuveden, č. 47, s. 102-110. ISSN 8756-3282.
  86. WITTE, Florian, Ondřej BERNATÍK, Katharina KIRCHNER, Jan MAŠEK, Annika MAHL, Pavel KREJČÍ, Stefan MUNDLOS, Alexandra SCHAMBONY, Vítězslav BRYJA a Sigmar STRICKER. Negative regulation of Wnt signaling mediated by CK1- phosphorylated Dishevelled via Ror2. FASEB JOURNAL. 2010, roč. 24, č. 7, s. 2417-2426. ISSN 0892-6638. doi:10.1096/fj.09-150615.
  87. KREJČÍ, Pavel, Shunichi MURAKAMI, Jiřina PROCHÁZKOVÁ, Lukáš TRANTÍREK, Katarína CHLEBOVÁ, Zhufeng OUYANG, Anie AKLIAN, Jiří SMUTNÝ, Vítězslav BRYJA, Alois KOZUBÍK a Wiliam R. WILCOX. Nf449 is a novel inhibitor of fibroblast growth factor receptor 3 (fgfr3) signaling active in chondrocytes and multiple myeloma cells. J. Biol. Chem. 2010, roč. 285, č. 27, s. 20644-20653. ISSN 0021-9258. doi:10.1074/jbc.M109.083626.
  88. 2009

  89. MATSUSHITA, Takehiko, William WILCOX, Chan YUK YU, Aya KAWANAMI, Hülya BÜKÜLMEZ, Gener BALMES, Pavel KREJČÍ, Pertchoui B MEKIKIAN, Kazuyuki OTANI, Isakichi YAMAURA, Matthew L. WARMAN, David GIVOL a Shunichi MURAKAMI. FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. Human Molecular Genetics. 2009, roč. 18, č. 2, 227-240. ISSN 0964-6906.
  90. KREJČÍ, Pavel, Jiřina PROCHÁZKOVÁ, Vítězslav BRYJA, Petra JELÍNKOVÁ, Kateřina PEJCHALOVÁ, Alois KOZUBÍK, Leslie Michels TOMPSON a William R. WILCOX. Fibroblast growth factor inhibits interferon gama-STAT1 and interleukin 6-STAT3 signaling in chondrocytes. Cellular Signalling. 2009, roč. 21, č. 1, s. 151-160. ISSN 0898-6568. doi:10.1016/j.cellsig.2008.10.006.
  91. CHLEBOVÁ, Katarína, Vítězslav BRYJA, Petr DVOŘÁK, Alois KOZUBÍK, W.R. WILCOX a Pavel KREJČÍ. High molecular weight FGF2: the biology of a nuclear growth factor. Cellular and molecular life sciences : CMLS. Switzerland, 2009, roč. 66, č. 2, s. 225-235. ISSN 1420-682X. doi:10.1007/s00018-008-8440-4.
  92. KREJČÍ, Pavel, Jiřina PROCHÁZKOVÁ, Vítězslav BRYJA, Alois KOZUBÍK a William WILCOX. Molecular pathology of the fibroblast growth factor family. Human Mutation. 2009, roč. 30, č. 9, s. 1245-55, 11 s. ISSN 1059-7794. doi:10.1002/humu.21067.
  93. 2008

  94. SALAZAR, Lisa, Tamara KASHIWADA, Pavel KREJČÍ, Paul MUCHOWSKI, Daniel DONOGHUE, William WILCOX a Leslie Michels THOMPSON. A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells. HUMAN MOLECULAR GENETICS. 2008, roč. 18, č. 11, s. 1951-1961. ISSN 0964-6906.
  95. KREJČÍ, Pavel, Lisa SALAZAR, Tamara A. KASHIWADA, Katarína CHLEBOVÁ, Alena SALAŠOVÁ, Leslie Michels THOMPSON, Vítězslav BRYJA, Alois KOZUBÍK a William R. WILCOX. Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage. PLoS ONE. 2008, roč. 3, č. 12, s. 72-81, 8 s. ISSN 1932-6203.
  96. KREJČÍ, Pavel, Lisa SALAZAR, Helen GOODRIDGE, Tamara KASHIWADA, Matthew SCHIBLER, Petra JELÍNKOVÁ, Leslie Michels THOMPSON, a William WILCOX. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes. JOURNAL OF CELL SCIENCE. 2008, roč. 121, č. 3, s. 272-81, 11 s. ISSN 0021-9533.
  97. 2007

  98. PEJCHALOVÁ, Kateřina, Pavel KREJČÍ a William R. WILCOX. C-natriuretic peptide: an important regulator of cartilage. Molecular Genetics and Metabolism. Elsevier, 2007, roč. 92, č. 3, s. 210-215. ISSN 1096-7192. doi:10.1016/j.ymgme.2007.06.014.
  99. KREJČÍ, Pavel, D. KRAKOW, P.B. MEKIKIAN a William R. WILCOX. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligandsexpressed in human fetal growth plate cartilage. Pediatric Research. Rotterdam: Williams and Wilkins, 2007, roč. 61, č. 3, s. 267-272. ISSN 0031-3998. doi:10.1203/pdr.0b013e318030d157.
  100. KREJČÍ, Pavel, Kateřina PEJCHALOVÁ a William R. WILCOX. Simple, mammalian cell-based assay for identification of inhibitors of the ErkMAP kinase pathway. Investigational New Drugs. 2007, roč. 25, č. 4, s. 391-395. ISSN 0167-6997. doi:10.1007/s10637-007-9054-7.
  101. KREJČÍ, Pavel, Kateřina PEJCHALOVÁ, B.E. ROSENBLOOM, F.P. ROSENFELT, E.L. TRAN, H. LAURELL a W.R. WILCOX. The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia. Journal of Leukocyte Biology. New York: Society for Leukocyte Biology, 2007, roč. 82, č. 6, s. 1363-1364. ISSN 0741-5400. doi:10.1189/jlb.0607425.
  102. 2006

  103. KREJČÍ, Pavel, B. MASRI, L. SALAZAR, C. FARRINGTON-ROCK, H. PRATS, L.M. THOMPSON a W.R. WILCOX. Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins. Journal of Biological Chemistry. Bethesda, USA: Amer. Soc. Biochem. Mol., 2006, roč. 282, č. 5, s. 2929-2936. ISSN 0021-9258. doi:10.1074/jbc.M606144200.
  104. KREJČÍ, Pavel, PB MEKIKIAN a WR WILCOX. The fibroblast growth factors in multiple myeloma. Leukemia. 2006, roč. 20, č. 6, s. 1165-1168. ISSN 0887-6924. doi:10.1038/sj.leu.2404202.
  105. 2005

  106. KREJČÍ, Pavel, B. MASRI, V. FONTAINE, P.B. MEKIKIAN, M. WEIS, H. PRATS a W.R. WILCOX. Interaction of fibroblast growth factor and C-natriuretic peptide signaling inregulation of chondrocyte proliferation and extracellular matrix homeostasis. Journal of Cell Science. Cambridge: Company of Biologists Ltd., 2005, roč. 118, č. 21, s. 5089-5100. ISSN 0021-9533. doi:10.1242/jcs.02618.
  107. 2004

  108. KREJČÍ, Pavel, Vítězslav BRYJA, Jiří PACHERNÍK, Aleš HAMPL, R. POGUE a W.R. WILCOX. FGFs inhibit proliferation and alter the cartilage-like phenotype of RCS cells. Experimental Cell Research. Elsevier, 2004, roč. 297, s. 152-164. ISSN 0014-4827.
  109. TAKAMINE, Y., Pavel KREJČÍ, P.B. MEKIKIAN a William R. WILCOX. Mutations in the EVC1 gene are not a common finding in the Ellis-van Creveld and short rib-polydactyly type III syndromes. American Journal of Medical Genetics. USA: Wiley-Liss, Inc., 2004, roč. 130A, č. 1, s. 96-97. ISSN 0148-7299. doi:10.1002/ajmg.a.20579.
  110. BRYJA, Vítězslav, Jiří PACHERNÍK, Ludmila FALDÍKOVÁ, Pavel KREJČÍ, R, POGUE, I, NEVRIVA, Petr DVOŘÁK a Aleš HAMPL. The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo. Biochimica et biophysica acta : Molecular Cell Research. Amsterdam: Elsevier, 2004, roč. 1691, 2-3, s. 105-116. ISSN 0167-4889. doi:10.1016/j.bbamer.2004.01.001.
  111. 2003

  112. KREJČÍ, Pavel, Jana MILFAITOVÁ, H. LAURELL, Aleš HAMPL a Petr DVOŘÁK. FGF-2 expression and its action in human leukemia and lymphoma cell lines. Leukemia. London : England: Nature Publishing Group, Specialist Jour, 2003, roč. 17, č. 4, s. 818-820. ISSN 0887-6924. doi:10.1038/sj.leu.2402861.
  113. 2002

  114. PRECLÍKOVÁ, H., Vítězslav BRYJA, Jiří PACHERNÍK, Pavel KREJČÍ, Petr DVOŘÁK a Aleš HAMPL. Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells. Cell Growth and Differentiation. 2002, roč. 13, s. 421-430. ISSN 1044-9523.
  115. PRECLÍKOVÁ, H., Vítězslav BRYJA, Jiří PACHERNÍK, Pavel KREJČÍ, Petr DVOŘÁK a Aleš HAMPL. Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells. Cell Growth and Differentiation. 2002, roč. 130A, č. 9, s. 421-430. ISSN 1044-9523.
  116. 2001

  117. KREJČÍ, Pavel, D. DVORÁKOVÁ, E. KRAHULCOVÁ, Jiří PACHERNÍK, Jiří MAYER, Aleš HAMPL a Petr DVOŘÁK. FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias. Leukemia. London : England: Nature Publishing Group, Specialist Jour, 2001, roč. 15, č. 2, s. 228-237. ISSN 0887-6924. doi:10.1038/sj.leu.2402012.
  118. DVORAKOVA, D., Pavel KREJČÍ, Jiří MAYER, Jiří FAJKUS, Aleš HAMPL a Petr DVOŘÁK. Changes in the expression of FGFR3 in patients with chronic myeloid leukaemia receiving transplants of allogeneic peripheral blood stem cells. British journal of haematology. England: Wiley-Blackwell, 2001, roč. 113, č. 3, s. 832-835. ISSN 0007-1048. doi:10.1046/j.1365-2141.2001.02829.x.
  119. VONDRÁČEK, Jan, M.A. SHEARD, Pavel KREJČÍ, Kateřina MINKSOVÁ, Jiřina HOFMANOVÁ a Alois KOZUBÍK. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells. Journal of Leukocyte Biology. New York: Society for Leukocyte Biology, 2001, roč. 69, č. 5, s. 794-802. ISSN 0741-5400.
  120. 1999

  121. JIRMANOVA, L., Jiřina PACHOLÍKOVÁ, Pavel KREJČÍ, A HAMPL a Petr DVOŘÁK. O-linked carbohydrates are required for FGF-2-mediated proliferation of mouse embryonic cells. The International journal of developmental biology. Spain: University Of The Basque Country Press, 1999, roč. 43, č. 6, s. 555-562. ISSN 0214-6282.
Zobrazit podrobně
Zobrazeno: 12. 6. 2021 19:55